Convoke Raises $8.6M to Build AI OS for Biopharma
Convoke’s platform turns uncooked information into deliverables, serving to drug builders speed up the trail from concept to market Immediately, Convoke, the AI-native working system for biopharma, introduced it has raised $8.6 million in seed capital. This financing was led by Kleiner Perkins and Dimension Capital, with participation from ACME, Comma Capital, Liquid2, Not Boring Capital, Audacious,…
